NEW YORK (360Dx) – By creating a reagent that's consumed by tuberculosis bacteria and causes infected cells to emit light, international researchers believe they have a new method for diagnosing tuberculosis that could broaden access to screening for people with TB symptoms.

The process, which is undergoing clinical trials to investigate its clinical utility, uses a reagent developed at Stanford University that combines a sugar molecule, called trehalose, and a chemical, called DMN, or 4-N,N-dimethylamino-1,8-naphthalimide.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.